Preferential Issue of shares & Increase in Authorised Capital & Inter alia, to consider and approve:- 1. Increase in Authorized share Capital of the Company pursuant to the applicable provisions of Companies Act, 2013. 2. Change in Memorandum of Association and Articles of Association of the Company pursuant to increase in Authorized Share Capital of the Company. 3. Consider appointment of registered valuer of Issue fund for the valuation report as per Companies Act, 2013 and SEBI (LODR). 4. Raising of funds by way of issue of Equity Shares on preferential allotment basis at such price as may be determined in accordance with rules and regulations of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended and to consider other matters consequential thereto, subject to the approval of the shareholders and all other authorities. 5. Consider appointment of Scrutinizer for EOGM. 6. Approve and decide Date, Time and Venue for Conducting Extra Ordinary General Meeting of the Company. 7. Approval of NOTICE of EOGM.

Employees Stock Option Plan

MONO PHARMACARE LIMITED has informed the Exchange about Board Meeting to be held on 02-Apr-2025 to consider Other business.

Inter alia, to consider and approve the following business: 1. To Consider and approve amendment(s) in the Object Clause of the Memorandum of Association (MOA) of the Company. 2. To Consider and approve Notice of 1st Extra-Ordinary General Meeting of the shareholders of the Company.

Inter-alia, to consider and approve:- (1) the First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the eligible Shareholders